டென்னிஸ் டர்பின் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டென்னிஸ் டர்பின். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டென்னிஸ் டர்பின் Today - Breaking & Trending Today

Aeterna Zentaris Announces Results of 2021 Annual Meeting of Shareholders


Ernst & Young LLP was also appointed as the Company’s independent auditor at the AGM.
The Company is an “Eligible Interlisted Issuer” as such term is defined in the TSX Company Manual. As an Eligible Interlisted Issuer, the Company has relied on an exemption pursuant to Section 602.1 of the TSX Company Manual from Section 613 of the TSX Company Manual, the effect of which is that, subject to the satisfaction of certain conditions prescribed by the Toronto Stock Exchange, the Company will not have to comply with certain Canadian requirements in connection with the Company’s long-term incentive plan. As a result, shareholders were not asked to approve the unallocated entitlements under the Company’s long-term incentive plan at the AGM. ....

Peter Edwards , Gilles Gagnon , Carolyn Egbert , Jenene Thomas , Dennis Turpin , Klaus Paulini , Aeterna Zentaris , Company On Twitter , European Commission , Company Manual , Aeterna Zentaris Inc , Toronto Stock Exchange , Ernst Young , Novo Nordisk , Annual General Meeting , Eligible Interlisted Issuer , பீட்டர் எட்வர்ட்ஸ் , கில்லஸ் க்யாநாய்ந் , கரோலின் எ.கா. , டென்னிஸ் டர்பின் , நிறுவனம் ஆன் ட்விட்டர் , ஐரோப்பிய தரகு , நிறுவனம் கையேடு , டொராண்டோ ஸ்டாக் பரிமாற்றம் , எர்னிஸ்ட இளம் , ஆண்டு ஜநரல் சந்தித்தல் ,

Lupin, Endoceutics focus on women's health in Canada


Lupin, Endoceutics focus on women s health in Canada
Lupin, Endoceutics focus on women s health in Canada
09 March 2021 | News
Source credit: Shutterstock
Lupin Pharma, a subsidiary of global pharma major Lupin Ltd, has announced a partnership with Endoceutics, a women’s health focused innovative Canadian biotech company, to commercialise Intrarosa® in Canada. 
Intrarosa® is Endoceutic’s flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of Prasterone.
Commenting on the partnership, Dr Sofia Mumtaz, President, Lupin Pharma Canada said, “We are very pleased to partner with Endoceutics to bring this long-awaited innovative product to the Canadian market. Intrarosa will not only expand and strengthen our product portfolio into women’s health in Canada but will cater to satisfy the unmet medical needs.” ....

Dennis Turpin , Lupin Ltd , Lupin Pharma , Lupin Pharma Canada , Chief Executive Officer , Postmenopausal Vulvovaginal Atrophy , Vaginal Ovule , டென்னிஸ் டர்பின் , லூபின் லிமிடெட் , லூபின் பார்மா , லூபின் பார்மா கனடா , தலைமை நிர்வாகி அதிகாரி ,

Lupin partners with Endoceutics to bring Intrarosa® to Canadian market

Lupin partners with Endoceutics to bring Intrarosa® to Canadian market
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Dennis Turpin , Lupin Ltd , Lupin Pharma , Lupin Pharma Canada , Chief Executive Officer , டென்னிஸ் டர்பின் , லூபின் லிமிடெட் , லூபின் பார்மா , லூபின் பார்மா கனடா , தலைமை நிர்வாகி அதிகாரி ,